Radiopharm Theranostics RADX
NASDAQ RADX
$2.15 +0.09 (+4.36%)
As of: Sep 10, 2026 · 10:29 AM EDT

Radiopharm Theranostics Ltd (RADX) Income from Non-Controlling Interests (2023 - 2025)

Radiopharm Theranostics' (RADX) quarterly Income from Non-Controlling Interests came in at -$1.6 million in Q2 2025, up 16.54% year-over-year from -$1.4 million in Q2 2024, and up 16.54% quarter-over-quarter from -$2.0 million in Q2 2024.

Generated on {Timestamp} © BusinessQuant.com
Generated on {Timestamp} Powered by BusinessQuant Logo
Analysis

Radiopharm Theranostics Ltd (RADX) Income from Non-Controlling Interests (2023 - 2025) Analysis & Trends

Radiopharm Theranostics (RADX) has reported Income from Non-Controlling Interests for 3 consecutive years, with -$1.6 million the latest figure, recorded in Q2 2025.

Peer Set

Peer Comparison

All peers
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2025 -1.64 Mn
Jun 30, 2024 -1.96 Mn
Jun 30, 2023 -162,529.00